CL
ONCS

CSS LLC’s OncoSec Medical Incorporated ONCS Stock Holding History

CSS LLC’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,921
Closed -$54K – 823
2020
Q1 		$54K Sell
1,921
-4
-0.2% -$149 ﹤0.01% 531
2019
Q4 		$77K Hold
1,925
– – ﹤0.01% 582
2019
Q3 		$83K Hold
1,925
– – 0.01% 520
2019
Q2 		$107K Buy
+1,925
New +$185K 0.01% 603

Other funds holding ONCS

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

CSS LLC's ONCS Position: Q2 2020 in Review

CSS LLC sold out of OncoSec Medical Incorporated (ONCS) in Q2 2020, closing a stake of 1,921 shares — an estimated $54K sold.

CSS LLC first reported a position in ONCS in Q2 2019 and held it in 4 quarters. The position peaked at $107K in Q2 2019. 16 funds tracked by Wall St. Rank hold ONCS as of Q2 2020.

  • CSS LLC reported no remaining OncoSec Medical Incorporated position as of Q2 2020 after selling out during the quarter.
  • CSS LLC sold 1,921 OncoSec Medical Incorporated shares in Q2 2020, an estimated $54K.
  • CSS LLC first reported a position in OncoSec Medical Incorporated in Q2 2019 and held it in 4 quarters.
  • CSS LLC's OncoSec Medical Incorporated position peaked at $107K in Q2 2019.
  • 16 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2020.

Based on CSS LLC's 13F filing for Q2 2020, filed 14 Aug 2020.